CathLab Digest

Digital Edition

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »





CLINICAL EVENTS CALENDAR

  • Start
    Mar 07,2010
    End
    Mar 12,2010
    Interventional Cardiology 2010: 25th Annual International Symposium: The Silvertree Hotel, Snowmass Village, CO
    tinyurl.com/mg5olq
  • Start
    Mar 14,2010
    End
    Mar 16,2010
    American College of Cardiology Scientific Session and i2 Summit 2010: Atlanta, GA
    acc.org
  • Start
    Mar 22,2010
    End
    Mar 26,2010
    Baylor University and Hankamer School of Business present: The 4th annual Global Business Forum
    http://www.baylor.edu/business/international/
  • Start
    Mar 25,2010
    End
    Mar 26,2010
    Balancing Your Own Health While Caring for Patients: Cocoa, FL (accredited)
    www.thegoldenlights.com

Cath Lab Digest Blogs

A Refresher on Pressure

Jon E. Jenkins RN RCIS's picture
Blog By: Jon E. Jenkins RN RCIS

In the era of vascular closure devices, the skill of achieving hemostasis by manual compression is almost becoming a lost art. It concerns me to see cath lab personnel that do not have a good technique for manual compression. When those closure devices fail, we need to be confident in our ability to manage hemostasis. Most seem to go with the "brute force" or "monster mash" technique. While this can be effective, it presents some concerns.

First, a "brute force" or "monster mash" technique is more uncomfortable for the patient. Second, it tends to cause more bruising and displaces the skin is a way that makes it difficult to assess if a hematoma is developing. Third, this technique is often not effective in our "well nourished" patients (specifically those with a tight, round belly). Finally, it is physically more demanding on the staff and often leads to the excuse "I'm just not strong enough to hold pressure," requiring calling upon your second hand to assist.


Prasugrel…The New Kid on the Block!

Annie Ruppert RN BSN's picture
Blog By: Annie Ruppert RN BSN

In July 2009, the FDA approved the drug prasugrel (Effient) in the treatment of acute coronary syndrome patients who had planned percutaneous coronary intervention. Prasugrel, in clinical trials, has been associated with a decrease in ischemic events (including stent thrombosis), but also an increase in the risk of bleeding, including fatal bleeding.1 One study showed that when compared to clopidogrel (Plavix), prasugrel had greater platelet inhibition. This study looked at patients receiving 60 mg prasugrel compared to clopidogrel 600 mg po as a loading dose, and also on maintenance doses of prasugrel 10 mg versus clopidogrel 150 mg daily.2 Due to the increased bleeding shown in clinical trials, prasugrel comes with a contraindication, or black box label, if the patient has a history of stroke and transient ischemic attack (TIA), if the patient is >75 years of age and if the patient is < 60 kg.


My First Blog: An Introduction

Jon E. Jenkins RN RCIS's picture
Blog By: Jon E. Jenkins RN RCIS

Hello, everyone. This is my first-ever attempt at blogging. So, as I move into a new arena of technology…ok, I know, you all are saying “Hey, Jon, welcome to 1997, the year the first blog was recorded.” Well, blame it on work schedule or being part of a family with 3 boys. I just haven’t had the time or know-how to participate in what some consider everyday life. I’m still trying to figure out Facebook. (Is that confusing to anyone else?)

I wanted to write my first blog as an introduction, but on a monthly basis, I will be blogging things related to cath lab life, education, research and sometimes posing questions to the readers for input.


New Zealand and US Cath Labs: What does socialized interventional cardiology look like?

Jason Money RN RCIS's picture
Blog By: Jason Money RN RCIS

Jason Money, RN, RCIS
Arkansas, US, and Bay of Plenty, New Zealand


When I first accepted a job in an interventional cath lab in New Zealand (NZ), I had no idea what to expect. I arrived in Auckland in May 1999 to work at Ascot Angiography, a private, hospital-based cath lab. My fears of “third world” healthcare were very quickly allayed when I saw the gleaming new Ascot Hospital. It is still the most luxurious hospital I have ever worked in, with the feel of an office building, rather than a hospital.


A Cost-Cutting Forum

Bob J. Basile SR. RT's picture
Blog By: Bob J. Basile SR. RT

We in the cath lab have many challenges ahead with all the healthcare insurance changes facing us.

We must begin to think outside the box for ways to lower our cost of providing high quality healthcare, as well as to create a database of where every penny goes.

For instance, here’s one thought, involving the creation of a private buying group. We poll all interested parties to find out which widgets everyone buys and at what cost they buy the widgets for — then our buying group bulk buys these widgets at the lowest costs possible (much like Walmart).

The group 'member' then buys the widgets from the buying group for costs lower than they'd likely be able to buy on their own. This can be for items like wires, catheters, pacemakers, and more. (Again, just one thought!)


Transradial vs. Femoral Access

Kenneth A. Gorsk RN RCIS RCSA FSICP's picture
Blog By: Kenneth A. Gorsk RN RCIS RCSA FSICP

Transradial coronary angiography and PCI seems to be everywhere these days. Pick up a cardiac journal, visit various cath-related websites, and you cannot escape being inundated with industry ads, articles on technique, and workshops offered at various conferences.

Data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) shows that currently, radial access is extremely rare in United States practice (1.32% of procedures done through the radial artery). However, in many European countries (such as France, Italy, and Spain) radial access is not only common, it is becoming the preferred route, not just when femoral arterial disease and obesity hinder vascular access. Just to our north, it is estimated that nearly 50% of cases are done radially in Canada; Norway and China are leading the way with 80-90% radial access.


Is Your Lab Using the SYNTAX Score?

Annie Ruppert RN BSN's picture
Blog By: Annie Ruppert RN BSN

Several trials have been conducted comparing coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) in patients with multi-vessel disease (MVD). CABG has done better mainly because there is a higher rate of revascularization in the percutaneous intervention arm of the studies. One recurring criticism has been that there was no measurable way to take into account the severity or complexity of the CAD. Obviously a patient with left main disease involving the ostium of the left anterior descending artery (LAD) and circumflex is a higher risk than a patient with mid right coronary artery (RCA), mid LAD and mid circumflex lesions. Yet both would be considered 3VD.

The SYNTAX Score was developed for use in the SYNTAX (SYNergy between PCI with TAXus and cardiac surgery) trial.1 It is lesion-based (limit 12 lesions) and each lesion can have one or more segments (no limit).




Cath Lab Surveys

Center for Education & Practice Development - Learning Module Femoral Artery Sheath Management(PDF) This learning module is designed for the Registered Nurse Division 1 working in areas where
patients are undergoing percutaneous cardiac catheterisation and interventions.

Cath Lab Digest Blogs

All Subscriptions are FREE to qualified cardiology professionals

#

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »


Newly Revised and Updated for 2009!

practical EP






Surgical Site Infection Education


REVIEW OUR OTHER
CARDIOLOGY BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • EP Lab Digest
  • Invasive Cardiology
  • Vascular Disease Management